NSE · BSE · Real-time

Breaking Corporate Events, Analysed in Real Time

High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.

All New Order Fund Raise Expansion Earning Call Regulatory Approval Production Started Product Launched
Aurobindo Pharma Secures USFDA Approval for First MDI Product in US$301M Market
Regulatory Approval

Aurobindo Pharma Secures USFDA Approval for First MDI Product in US$301M Market

Aurobindo Pharma has received final USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, marking its entry into the metered-dose inhaler (MDI) segment. The product targets a US market valued at approximately US$301 million and will be manufactured in North Carolina.

Aurobindo Pharma Limited
15 Sep 2026 4 min read
Anand Rathi Wealth Subsidiary ARFME Receives IFSCA Registration for GIFT City Operations
Regulatory Approval

Anand Rathi Wealth Subsidiary ARFME Receives IFSCA Registration for GIFT City Operations

Anand Rathi Wealth’s wholly-owned subsidiary, Anand Rathi FME (IFSC) Private Limited, has received a certificate of registration from the International Financial Services Centres Authority. This approval enables the entity to commence non-retail fund management activities at GIFT City, Gujarat.

Anand Rathi Wealth Ltd
14 Sep 2026 4 min read
Raghav Productivity Enhancers Secures Two Patents for Automated Ramming Mass Technology
Regulatory Approval

Raghav Productivity Enhancers Secures Two Patents for Automated Ramming Mass Technology

Raghav Productivity Enhancers' wholly owned subsidiary has been granted two Indian patents for automated quartz processing and silo-level interlock systems. These technological advancements provide 20-year exclusivity for the company's proprietary ramming mass production methods.

Raghav Productivity Enhancers Ltd
12 Sep 2026 4 min read
BSE Limited Secures SEBI Approval for Re-appointment of Jagannath Mukkavilli as Director
Regulatory Approval

BSE Limited Secures SEBI Approval for Re-appointment of Jagannath Mukkavilli as Director

BSE Limited has received formal approval from the Securities and Exchange Board of India (SEBI) for the re-appointment of Shri Jagannath Mukkavilli as a Non-Independent Director. This regulatory nod follows the prior approval granted by the company's shareholders during the 21st Annual General Meeting.

BSE Limited
11 Sep 2026 4 min read
Shilpa Medicare Secures SEC Approval for World-First OERIS Long-Acting Injectable
Regulatory Approval

Shilpa Medicare Secures SEC Approval for World-First OERIS Long-Acting Injectable

Shilpa Medicare has received final approval from the CDSCO Subject Expert Committee for OERIS, a world-first extended-release ondansetron injection. The product, used for managing chemotherapy-induced nausea, offers five days of protection from a single dose and holds patent security until 2039.

Shilpa Medicare Ltd
11 Sep 2026 4 min read
Kalyani Cast-Tech Receives CBIC Approval for Shivlakha Inland Container Depot in Kutch
Regulatory Approval

Kalyani Cast-Tech Receives CBIC Approval for Shivlakha Inland Container Depot in Kutch

Kalyani Cast-Tech Limited has received a Letter of Intent from the Ministry of Finance to establish an Inland Container Depot in Shivlakha, Gujarat. This regulatory clearance anchors the company's transition into a diversified rail, manufacturing, and logistics platform.

Kalyani Cast-Tech Ltd
11 Sep 2026 4 min read
Acutaas Chemicals Secures Indian Patent for 2,4-Dimethylthiophenol Process
Regulatory Approval

Acutaas Chemicals Secures Indian Patent for 2,4-Dimethylthiophenol Process

Acutaas Chemicals Limited has been granted a process patent by the Indian Patent Office for its indigenously developed method to prepare 2,4-dimethylthiophenol. This grant secures exclusive rights for a 20-year term and brings the company's total patent portfolio to 11 specialized processes.

Acutaas Chemicals Ltd
10 Sep 2026 4 min read
ICICI Prudential AMC Receives RBI Approval for 9.95% Stake in Four Private Banks
Regulatory Approval

ICICI Prudential AMC Receives RBI Approval for 9.95% Stake in Four Private Banks

ICICI Prudential Asset Management Company has secured regulatory clearance from the Reserve Bank of India to increase its aggregate holding in four major private sector banks. The approval allows the AMC to acquire up to 9.95% of the paid-up equity capital or voting rights in Kotak Mahindra Bank, AU Small Finance Bank, CSB Bank, and DCB Bank.

ICICI Prudential Asset Management Company Ltd
9 Sep 2026 4 min read
RBI Approves ICICI Prudential AMC to Acquire Up to 9.95% Stake in AU Small Finance Bank
Regulatory Approval

RBI Approves ICICI Prudential AMC to Acquire Up to 9.95% Stake in AU Small Finance Bank

AU Small Finance Bank has secured regulatory approval from the Reserve Bank of India for ICICI Prudential Asset Management Company to increase its aggregate holding to 9.95%. This approval covers various schemes including mutual funds, AIFs, and PMS clients, reinforcing institutional interest in the bank.

AU Small Finance Bank Limited
9 Sep 2026 4 min read